Bioequivalence Study of Esomeprazole From Stomopral 40 mg Capsules Contain Enteric Coated Pellets (Future Pharmaceuticals Industries, Egypt) and Nexium 40 mg Delayed Release Capsules (AstraZeneca Sweden, Product of France)

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

March 18, 2021

Primary Completion Date

April 1, 2021

Study Completion Date

May 28, 2021

Conditions

Healthy

Interventions

DRUG

Stomopral

1 capsule contains 40 mg Esomeprazole

DRUG

Nexium

1 capsule contains 40 mg Esomeprazole

Trial Locations (1)

Genuine Research Center GRC, Cairo